Fire: Created page with "{{Navbox | name = Growth factor receptor modulators/ja | title = Growth factor receptor/jaモジュレーター | state = {{{state|collapsed}}} | bodyclass = hlist | groupstyle = text-align:center; | border = {{{border|}}} | group1 = アンジオポエチン | list1 = * ''作動薬:'' Angiopoietin 1/ja * Angiopoietin 4/ja..."

2024-03-18T02:17:05Z

Created page with "{{Navbox | name = Growth factor receptor modulators/ja | title = Growth factor receptor/ja モジュレーター | state = {{{state<includeonly>|collapsed</includeonly>}}} | bodyclass = hlist | groupstyle = text-align:center; | border = {{{border|}}} | group1 = アンジオポエチン | list1 = * ''作動薬:'' Angiopoietin 1/ja * Angiopoietin 4/ja..."

New page

{{Navbox
| name = Growth factor receptor modulators/ja
| title = [[Growth factor receptor/ja]][[receptor modulator/ja|モジュレーター]]
| state = {{{state<includeonly>|collapsed</includeonly>}}}
| bodyclass = hlist
| groupstyle = text-align:center;
| border = {{{border|}}}

| group1 = [[Angiopoietin receptor/ja|アンジオポエチン]]
| list1 =
* ''作動薬:'' [[Angiopoietin 1/ja]]
* [[Angiopoietin 4/ja]]

* ''拮抗薬:'' [[Angiopoietin 2/ja]]
* [[Angiopoietin 3/ja]]

* ''キナーゼ阻害薬:'' [[Altiratinib/ja]]
* [[CE-245677/ja]]
* [[Rebastinib/ja]]

* ''抗体:'' [[Evinacumab/ja]] (アンジオポエチン3に対して)
* [[Nesvacumab/ja]] (アンジオポエチン2に対して)

| group2 = [[Ciliary neurotrophic factor receptor/ja|CNTF]]
| list2 =
* ''作動薬:'' [[Axokine/ja]]
* [[Ciliary neurotrophic factor receptor/ja|CNTF]]
* [[Dapiclermin/ja]]

| group3 = [[Epidermal growth factor receptor/ja|EGF (ErbB)]]
| list3 = {{Navbox|subgroup
| groupstyle = text-align:center;



| group1 = [[Epidermal growth factor receptor/ja|EGF (ErbB1/HER1)]]
| list1 =
* ''Agonists'': [[Amphiregulin/ja]]
* [[Betacellulin/ja]]
* [[Epidermal growth factor/ja|EGF (ウロガストロン)]]
* [[Epigen/ja]]
* [[Epiregulin/ja]]
* [[Heparin-binding EGF-like growth factor/ja|ヘパリン結合EGF様成長因子 (HB-EGF)]]
* [[Murodermin/ja]]
* [[Nepidermin/ja]]
* [[Transforming growth factor alpha/ja|トランスフォーミング成長因子アルファ (TGFα)]]

* ''キナーゼ阻害薬:'' [[Afatinib/ja]]
* [[Agerafenib/ja]]
* [[Brigatinib/ja]]
* [[Canertinib/ja]]
* [[Dacomitinib/ja]]
* [[Erlotinib/ja]]
* [[Gefitinib/ja]]
* [[Grandinin/ja]]
* [[Icotinib/ja]]
* [[Lapatinib/ja]]
* [[Neratinib/ja]]
* [[Osimertinib/ja]]
* [[Vandetanib/ja]]
* [[WHI-P 154/ja]]

* ''抗体:'' [[Cetuximab/ja]]
* [[Depatuxizumab/ja]]
* [[Depatuxizumab mafodotin/ja]]
* [[Futuximab/ja]]
* [[Imgatuzumab/ja]]
* [[Matuzumab/ja]]
* [[Necitumumab/ja]]
* [[Nimotuzumab/ja]]
* [[Panitumumab/ja]]
* [[Zalutumumab/ja]]

| group2 = [[HER2/neu/ja|ErbB2/HER2]]
| list2 =
* ''作動薬'': ''不明/なし''

* ''抗体:'' [[Ertumaxomab/ja]]
* [[Pertuzumab/ja]]
* [[Trastuzumab/ja]]
* [[Trastuzumab deruxtecan/ja]]
* [[Trastuzumab duocarmazine/ja]]
* [[Trastuzumab emtansine/ja]]

* ''キナーゼ阻害薬:'' [[Afatinib/ja]]
* [[Lapatinib/ja]]
* [[Mubritinib/ja]]
* [[Neratinib/ja]]
* [[Tucatinib/ja]]

| group3 = [[HER3/ja|ErbB3/HER3]]
| list3 =
* ''作動薬:'' [[Neuregulin/ja|神経グリン（ヘレグリン）]] ([[Neuregulin-1/ja|1]], [[NRG2/ja|2]], [[CSPG5/ja|6 (ニューログリカンC)]])

* ''抗体:'' [[Duligotumab/ja]]
* [[Patritumab/ja]]
* [[Seribantumab/ja]]

| group4 = [[HER4/ja|ErbB4/HER4]]
| list4 =
* ''作動薬:'' [[Betacellulin/ja]]
* [[Epigen/ja]]
* [[Heparin-binding EGF-like growth factor/ja|ヘパリン結合EGF様成長因子 (HB-EGF)]]
* [[Neuregulin/ja|神経グリン（ヘレグリン）]] ([[Neuregulin-1/ja|1]], [[NRG2/ja|2]], [[NRG3/ja|3]], [[NRG4/ja|4]], [[Tomoregulin/ja|5 (トモレグリン, TMEFF)]])

}}

| group4 = [[Fibroblast growth factor receptor/ja|FGF]]
| list4 = {{Navbox|subgroup
| groupstyle = text-align:center;



| group1 = [[Fibroblast growth factor receptor 1/ja|FGFR1]]
| list1 =
* ''作動薬:'' [[Ersofermin/ja]]
* [[Fibroblast growth factor/ja|FGF]] ([[FGF1/ja|1]], [[FGF2/ja|2 (bFGF)]], [[FGF3/ja|3]], [[FGF4/ja|4]], [[FGF5/ja|5]], [[FGF6/ja|6]], [[FGF8/ja|8]], [[FGF10/ja|10 (KGF2)]], [[FGF20/ja|20]])
* [[Repifermin/ja]]
* [[Selpercatinib/ja]]
* [[Trafermin/ja]]
* [[Velafermin/ja]]

| group2 = [[Fibroblast growth factor receptor 2/ja|FGFR2]]
| list2 =
* ''作動薬:'' [[Ersofermin/ja]]
* [[Fibroblast growth factor/ja|FGF]] ([[FGF1/ja|1]], [[FGF2/ja|2 (bFGF)]], [[FGF3/ja|3]], [[FGF4/ja|4]], [[FGF5/ja|5]], [[FGF6/ja|6]], [[FGF7/ja|7]] ([[keratinocyte growth factor/ja|KGF]]), [[FGF8/ja|8]], [[FGF9/ja|9]], [[FGF10/ja|10 (KGF2)]], [[FGF17/ja|17]], [[FGF18/ja|18]], [[FGF22/ja|22]])
* [[Palifermin/ja]]
* [[Repifermin/ja]]
* [[Selpercatinib/ja]]
* [[Sprifermin/ja]]
* [[Trafermin/ja]]

* ''抗体:'' [[Aprutumab/ja]]
* [[Aprutumab ixadotin/ja]]

* ''キナーゼ阻害薬:'' [[Infigratinib/ja]]

| group3 = [[Fibroblast growth factor receptor 3/ja|FGFR3]]
| list3 =
* ''作動薬:'' [[Ersofermin/ja]]
* [[Fibroblast growth factor/ja|FGF]] ([[FGF1/ja|1]], [[FGF2/ja|2 (bFGF)]], [[FGF4/ja|4]], [[FGF8/ja|8]], [[FGF9/ja|9]], [[FGF18/ja|18]], [[FGF23/ja|23]])
* [[Selpercatinib/ja]]
* [[Sprifermin/ja]]
* [[Trafermin/ja]]

* ''抗体:'' [[Burosumab/ja]] (FGF23に対して)

| group4 = [[Fibroblast growth factor receptor 4/ja|FGFR4]]
| list4 =
* ''作動薬:'' [[Ersofermin/ja]]
* [[Fibroblast growth factor/ja|FGF]] ([[FGF1/ja|1]], [[FGF2/ja|2 (bFGF)]], [[FGF4/ja|4]], [[FGF6/ja|6]], [[FGF8/ja|8]], [[FGF9/ja|9]], [[FGF19/ja|19]])
* [[Trafermin/ja]]

| group5 = [[Fibroblast growth factor receptor-like 1/ja|FGFRL1 (FGFR5)]]
| list5 =

| group6 = [[Fibroblast growth factor receptor-like 1/ja|PERB1 (FGFR6)]]
| list6 =

| group7 = 未分類
| list7 =
* ''作動薬:'' [[FGF15/19/ja]]

}}

| group5 = [[Hepatocyte growth factor receptor/ja|HGF (c-Met)]]
| list5 =
* ''作動薬'': [[Fosgonimeton/ja]]
* [[Hepatocyte growth factor/ja]]

* ''ポテンショメーター:'' [[Dihexa/ja|ジヘキサ (PNB-0408)]]

* ''キナーゼ阻害薬:'' [[Altiratinib/ja]]
* [[AM7 (drug)/ja|AM7]]
* [[AMG-458/ja]]
* [[Amuvatinib/ja]]
* [[BMS-777607/ja]]
* [[Cabozantinib/ja]]
* [[Capmatinib/ja]]
* [[Crizotinib/ja]]
* [[Foretinib/ja]]
* [[Golvatinib/ja]]
* [[INCB28060/ja]]
* [[JNJ-38877605/ja]]
* [[K252a/ja]]
* [[MK-2461/ja]]
* [[PF-04217903/ja]]
* [[PF-2341066/ja]]
* [[PHA-665752/ja]]
* [[SU-11274/ja]]
* [[Tivantinib/ja]]
* [[Volitinib/ja]]

* ''抗体:'' [[Emibetuzumab/ja]]
* [[Ficlatuzumab/ja]]
* [[Flanvotumab/ja]]
* [[Onartuzumab/ja]]
* [[Rilotumumab/ja]]
* [[Telisotuzumab/ja]]
* [[Telisotuzumab vedotin/ja]]

| group6 = [[Somatomedin receptor/ja|IGF]]
| list6 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[Insulin-like growth factor 1 receptor/ja|IGF-1]]
| list1 =
* ''作動薬'': [[des(1-3)IGF-1/ja]]
* [[Insulin-like growth factor 1/ja|インスリン様成長因子-1（ソマトメジンC）]]
* [[IGF-1 LR3/ja]]
* [[Insulin-like growth factor 2/ja|インスリン様成長因子-2（ソマトメジンA）]]
* [[Insulin/ja]]
* [[Mecasermin/ja]]
* [[Mecasermin rinfabate/ja]]

* ''キナーゼ阻害薬:'' [[BMS-754807/ja]]
* [[Linsitinib/ja]]
* [[NVP-ADW742/ja]]
* [[NVP-AEW541/ja]]
* [[OSl-906/ja]]

* ''抗体:'' [[AVE-1642/ja]]
* [[Cixutumumab/ja]]
* [[Dalotuzumab/ja]]
* [[Figitumumab/ja]]
* [[Ganitumab/ja]]
* [[Robatumumab/ja]]
* [[R1507/ja]]
* [[Teprotumumab/ja]]
* [[Xentuzumab/ja]] (IGF-1とIGF-2に対して)

| group2 = [[Insulin-like growth factor 2 receptor/ja|IGF-2]]
| list2 =
* ''作動薬'': [[Insulin-like growth factor 2/ja|インスリン様成長因子-2（ソマトメジンA）]]

* ''抗体:'' [[Dusigitumab/ja]]
* [[Xentuzumab/ja]] (IGF-1とIGF-2に対して)

| group3 = その他
| list3 =
* ''結合タンパク質:'' [[Insulin-like growth factor-binding protein/ja|IGFBP]] ([[IGFBP1/ja|1]], [[IGFBP2/ja|2]], [[IGFBP3/ja|3]], [[IGFBP4/ja|4]], [[IGFBP5/ja|5]], [[IGFBP6/ja|6]], [[IGFBP7/ja|7]])

* ''標的不明の開裂生成物／誘導体:'' [[Glypromate/ja|グリプロメート (GPE, (1-3)IGF-1)]]
* [[Trofinetide/ja]]

}}

| group7 = [[Low-affinity nerve growth factor receptor/ja|LNGF (p75NTR)]]
| list7 =
* ''作動薬:'' [[Brain-derived neurotrophic factor/ja|BDNF]]
* [[BNN-20/ja]]
* [[BNN-27/ja]]
* [[Cenegermin/ja]]
* [[Dehydroepiandrosterone/ja|DHEA]]
* [[Dehydroepiandrosterone sulfate/ja|DHEA-S]]
* [[Nerve growth factor/ja|NGF]]
* [[Neurotrophin-3/ja|NT-3]]
* [[Neurotrophin-4/ja|NT-4]]

* ''拮抗薬:'' [[ALE-0540/ja]]
* [[Dexamethasone/ja]]
* [[EVT-901/ja|EVT-901 (SAR-127963)]]
* [[Testosterone/ja]]

* ''抗体:'' ''NGFに対して:'' [[ABT-110/ja|ABT-110 (PG110)]]
* [[ASP-6294/ja]]
* [[Fasinumab/ja]]
* [[Frunevetmab/ja]]
* [[Fulranumab/ja]]
* [[MEDI-578/ja]]
* [[Ranevetmab/ja]]
* [[Tanezumab/ja]]

* ''アプタマー:'' ''NGFに対して:'' [[RBM-004/ja]]

* ''デコイ受容体:'' [[LEVI-04/ja|LEVI-04 (p75NTR-Fc)]]

| group8 = [[Platelet-derived growth factor receptor/ja|PDGF]]
| list8 =
* ''作動薬:'' [[Becaplermin/ja]]
* [[Platelet-derived growth factor/ja|血小板由来成長因子]] ([[PDGFA/ja|A]], [[PDGFB/ja|B]], [[PDGFC/ja|C]], [[PDGFD/ja|D]])

* ''キナーゼ阻害薬'' [[Agerafenib/ja]]
* [[Avapritinib/ja]]
* [[Axitinib/ja]]
* [[Crenolanib/ja]]
* [[Imatinib/ja]]
* [[Lenvatinib/ja]]
* [[Masitinib/ja]]
* [[Motesanib/ja]]
* [[Nintedanib/ja]]
* [[Pazopanib/ja]]
* [[Radotinib/ja]]
* [[Quizartinib/ja]]
* [[Ripretinib/ja]]
* [[Sunitinib/ja]]
* [[Sorafenib/ja]]
* [[Toceranib/ja]]

* ''抗体:'' [[Olaratumab/ja]]
* [[Ramucirumab/ja]]
* [[Tovetumab/ja]]

| group9 = [[RET proto-oncogene/ja/ja|RET (GFL)]]
| list9 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[GFRα1/ja]]
| list1 =
* ''作動薬:'' [[Glial cell line-derived neurotrophic factor/ja|グリア細胞由来神経栄養因子 (GDNF)]]
* [[Liatermin/ja]]

* ''キナーゼ阻害剤:'' [[Vandetanib/ja]]

| group2 = [[GFRα2/ja]]
| list2 =
* ''作動薬:'' [[Neurturin/ja|Neurturin (NRTN)]]

* ''キナーゼ阻害薬:'' [[Vandetanib/ja]]

| group3 = [[GFRα3/ja]]
| list3 =
* ''作動薬'' [[Artemin/ja|アルテミン (ARTN)]]

* ''キナーゼ阻害薬:'' [[Vandetanib/ja]]

| group4 = [[GFRα4/ja]]
| list4 =
* ''作動薬:'' [[Persephin/ja|ペルセフィン (PSPN)]]

* ''キナーゼ阻害薬:'' [[Vandetanib/ja]]

| group5 = 未分類
| list5 =
* ''キナーゼ阻害薬:'' [[Agerafenib/ja]]

}}

| group10 = [[CD117/ja|SCF (c-Kit)]]
| list10 =
* ''作動薬:'' [[Ancestim/ja]]
* [[Stem cell factor/ja]]

* ''キナーゼ阻害薬s:'' [[Agerafenib/ja]]
* [[Axitinib/ja]]
* [[Dasatinib/ja]]
* [[Imatinib/ja]]
* [[Masitinib/ja]]
* [[Nilotinib/ja]]
* [[Pazopanib/ja]]
* [[Quizartinib/ja]]
* [[Sorafenib/ja]]
* [[Sunitinib/ja]]
* [[Toceranib/ja]]

| group11 = [[Transforming growth factor beta receptor/ja|TGFβ]]
| list11 =
* 代わりに[[Template:TGFβ_receptor_superfamily_modulators|ここを]]参照

| group12 = [[Trk receptor/ja|Trk]]
| list12 = {{Navbox|subgroup
| groupstyle = text-align:center;

| group1 = [[TrkA receptor/ja|TrkA]]
| list1 =
* ''作動薬:'' [[Amitriptyline/ja]]
* [[BNN-20/ja]]
* [[BNN-27/ja]]
* [[Cenegermin/ja]]
* [[Dehydroepiandrosterone/ja|DHEA]]
* [[Dehydroepiandrosterone sulfate/ja|DHEA-S]]
* [[Gambogic amide/ja]]
* [[Nerve growth factor/ja|NGF]]
* [[Tavilermide/ja]]

* ''拮抗薬:'' [[ALE-0540/ja]]
* [[Dexamethasone/ja]]
* [[FX007/ja]]
* [[Testosterone/ja]]

* ''ネガティブアロステリックモジュレーター:'' [[VM-902A/ja]]

* ''キナーゼ阻害剤:'' [[Altiratinib/ja]]
* [[AZD-6918/ja]]
* [[CE-245677/ja]]
* [[CH-7057288/ja]]
* [[DS-6051/ja]]
* [[Entrectinib/ja]]
* [[GZ-389988/ja]]
* [[K252a/ja]]
* [[Larotrectinib/ja]]
* [[Lestaurtinib/ja]]
* [[Milciclib/ja]]
* [[ONO-4474/ja]]
* [[ONO-5390556/ja]]
* [[PLX-7486/ja]]
* [[Rebastinib/ja]]
* [[SNA-120/ja|SNA-120 (pegylated K252a)]])

* ''抗体:'' ''TrkAに対して:'' [[GBR-900/ja]]; ''NGFに対して:'' [[ABT-110/ja|ABT-110 (PG110)]]
* [[ASP-6294/ja]]
* [[Fasinumab/ja]]
* [[Frunevetmab/ja]]
* [[Fulranumab/ja]]
* [[MEDI-578/ja]]
* [[Ranevetmab/ja]]
* [[Tanezumab/ja]]

* ''アプタマー:'' ''NGFに対して:'' [[RBM-004/ja]]

* ''デコイ受容体:'' [[ReN-1820/ja|ReN-1820 (TrkAd5)]]

| group2 = [[TrkB receptor/ja|TrkB]]
| list2 =
* ''Agonists:'' [[3,7-Dihydroxyflavone/ja|3,7-DHF]]
* [[3,7,8,2'-Tetrahydroxyflavone/ja|3,7,8,2'-THF]]
* [[4'-Dimethylamino-7,8-dihydroxyflavone/ja|4'-DMA-7,8-DHF]]
* [[7,3′-Dihydroxyflavone/ja|7,3'-DHF]]
* [[7,8-Dihydroxyflavone/ja|7,8-DHF]]
* [[7,8,2'-Trihydroxyflavone/ja|7,8,2'-THF]]
* [[7,8,3'-Trihydroxyflavone/ja|7,8,3'-THF]]
* [[Amitriptyline/ja]]
* [[Brain-derived neurotrophic factor/ja|BDNF]]
* [[BNN-20/ja]]
* [[Deoxygedunin/ja]]
* [[Deprenyl/ja]]
* [[Diosmetin/ja]]
* [[DMAQ-B1/ja]]
* [[HIOC/ja]]
* [[LM22A-4/ja]]
* [[N-Acetylserotonin/ja]]
* [[Neurotrophin-3/ja|NT-3]]
* [[Neurotrophin-4/ja|NT-4]]
* [[Norwogonin/ja|ノルウェーゴニン (5,7,8-THF)]]
* [[R7 (drug)/ja|R7]]
* [[R13 (drug)/ja|R13]]
* [[TDP6/ja]]

* ''拮抗薬:'' [[ANA-12/ja]]
* [[Cyclotraxin B/ja]]
* [[Gossypetin/ja|ゴシペチン (3,5,7,8,3',4'-HHF)]]

* ''リガンド:'' [[Dehydroepiandrosterone/ja|DHEA]]

* ''キナーゼ阻害剤:'' [[Altiratinib/ja]]
* [[AZD-6918/ja]]
* [[CE-245677/ja]]
* [[CH-7057288/ja]]
* [[DS-6051/ja]]
* [[Entrectinib/ja]]
* [[GZ-389988/ja]]
* [[K252a/ja]]
* [[Larotrectinib/ja]]
* [[Lestaurtinib/ja]]
* [[ONO-4474/ja]]
* [[ONO-5390556/ja]]
* [[PLX-7486/ja]]

| group3 = [[TrkC receptor/ja|TrkC]]
| list3 =
* ''作動薬:'' [[BNN-20/ja]]
* [[Dehydroepiandrosterone/ja|DHEA]]
* [[Neurotrophin-3/ja|NT-3]]

* ''キナーゼ阻害剤:'' [[Altiratinib/ja]]
* [[AZD-6918/ja]]
* [[CE-245677/ja]]
* [[CH-7057288/ja]]
* [[DS-6051/ja]]
* [[Entrectinib/ja]]
* [[GZ-389988/ja]]
* [[K252a/ja]]
* [[Larotrectinib/ja]]
* [[Lestaurtinib/ja]]
* [[ONO-4474/ja]]
* [[ONO-5390556/ja]]
* [[PLX-7486/ja]]

}}

| group13 = [[Vascular endothelial growth factor receptor/ja|VEGF]]
| list13 =
* ''作動薬:'' [[Placental growth factor/ja|胎盤成長因子 (PGF)]]
* [[Ripretinib/ja]]
* [[Telbermin/ja]]
* [[Vascular endothelial growth factor/ja|VEGF]] ([[Vascular endothelial growth factor A/ja|A]], [[Vascular endothelial growth factor B/ja|B]], [[Vascular endothelial growth factor C/ja|C]], [[Vascular endothelial growth factor D/ja|D (FIGF)]])

* ''アロステリック・モジュレーター:'' [[Cyclotraxin B/ja]]

* ''キナーゼ阻害剤:'' [[Agerafenib/ja]]
* [[Altiratinib/ja]]
* [[Axitinib/ja]]
* [[Cabozantinib/ja]]
* [[Cediranib/ja]]
* [[Fruquintinib/ja]]
* [[Lapatinib/ja]]
* [[Lenvatinib/ja]]
* [[Motesanib/ja]]
* [[Nintedanib/ja]]
* [[Pazopanib/ja]]
* [[Pegaptanib/ja]]
* [[Rebastinib/ja]]
* [[Regorafenib/ja]]
* [[Semaxanib/ja]]
* [[Sorafenib/ja]]
* [[Sunitinib/ja]]
* [[Toceranib/ja]]
* [[Tivozanib/ja]]
* [[Vandetanib/ja]]
* [[WHI-P 154/ja]]

* ''抗体:'' [[Alacizumab pegol/ja]]
* [[Bevacizumab/ja]]
* [[Icrucumab/ja]]
* [[Ramucirumab/ja]]
* [[Ranibizumab/ja]]

* ''デコイ受容体:'' [[Aflibercept/ja]]

| group14 =その他
| list14 =
* ''付加的成長因子:'' [[Adrenomedullin/ja]]
* [[Colony-stimulating factor/ja]] ([[Template:Cytokine receptor modulators/ja|ここを]]代わりに参照)
* [[Connective tissue growth factor/ja|結合組織成長因子 (CTGF)]]
* [[Ephrin/ja]] ([[EFNA1/ja|A1]], [[EFNA2/ja|A2]], [[EFNA3/ja|A3]], [[EFNA4/ja|A4]], [[EFNA5/ja|A5]], [[EFNB1/ja|B1]], [[EFNB2/ja|B2]], [[EFNB3/ja|B3]])
* [[Erythropoietin/ja]] ([[Template:Cytokine receptor modulators/ja|ここを]]代わりに参照)
* [[Glucose-6-phosphate isomerase/ja|グルコース-6-リン酸イソメラーゼ (GPI; PGI, PHI, AMF)]]
* [[Glia maturation factor/ja|グリア成熟因子 (GMF)]]
* [[Hepatoma-derived growth factor/ja|肝腫由来成長因子 (HDGF)]]
* [[Interleukin/ja]]/[[T-cell growth factor/ja]] ([[Template:Cytokine receptor modulators/ja|ここを]]代わりに参照)
* [[Leukemia inhibitory factor/ja|白血病抑制因子 (LIF)]]
* [[Macrophage-stimulating protein/ja|マクロファージ刺激タンパク質 (MSP; HLP, HGFLP)]]
* [[Midkine/ja|ミッドカイン (NEGF2)]]
* [[Migration-stimulating factor/ja|遊走刺激因子 (MSF; PRG4)]]
* [[Oncomodulin/ja]]
* [[Pituitary adenylate cyclase-activating peptide/ja|下垂体アデニル酸シクラーゼ活性化ペプチド (PACAP)]]
* [[Pleiotrophin/ja]]
* [[Renalase/ja]]
* [[Thrombopoietin/ja]] ([[Template:Cytokine receptor modulators/ja|ここを]]代わりに参照)
* [[Wnt signaling pathway/ja|Wntシグナル伝達タンパク質]]

* ''付加的成長因子受容体モジュレーター:'' [[Cerebrolysin/ja]] (ニューロトロフィン混合物)

}}<noinclude>
{{collapsible option}}
[[Category:Drug templates by receptor, channel, or pump]]
</noinclude>

Template:Growth factor receptor modulators/ja - Revision history